Gemfibrozil
Gemfibrozil is a PPARα agonist that promotes fatty acid oxidation and lipoprotein lipase synthesis, enhancing triglyceride clearance and reducing apoC-III and VLDL-C. It also increases apoA-I/A-II expression to raise HDL-C. This fibric acid derivative is used in research on dyslipidemia, atherosclerosis, and metabolic syndrome in both cellular and animal models.
Product Specifications
CAS Number
25812-30-0
Product Name Alternative
Lopid, inhibit, Jezil, Gemfibrozil, Inhibitor, CI 719, CI719, CI-719, Decrelip, Cytochrome P450, CYPs, CYP1A2, CYP2C9, AdrenergicReceptor, Adrenergic Receptor, Peroxisome proliferator-activated receptors, PPAR, PPARα
Field of Research
Metabolism Research, Molecular Biology, Neuroscience, Pharmacology & Drug Discovery
Purity
98.59% (May vary between batches)
Solubility
DMSO:250 mg/mL (998.68 mM) ; Ethanol:47 mg/mL (187.75 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (7.99 mM)
Smiles
CC1=CC (OCCCC (C) (C) C (O) =O) =C (C) C=C1
Molecular Formula
C15H22O3
Molecular Weight
250.33
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1540804 1.0 µg DNA
OR7E158P sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
K6949604 1.0 µg DNA
Trib1 sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details 